Gorwood, Philip
Benichou, Jacques
Moore, Nicolas
Wattez, Marine
Secouard, Marie-Cécile
Desobry, Xavier
Picarel-Blanchot, Françoise http://orcid.org/0000-0001-8232-0793
de Bodinat, Christian
Funding for this research was provided by:
Servier
Article History
First Online: 29 July 2020
Declarations
:
: This study was sponsored by Servier (Suresnes, France), and Servier employees were involved in the collection and analysis of data.
: This study was performed in accordance with the principles stated in the Declaration of Helsinki (Finland), Good Pharmacoepidemiology Practices, Ethical Guidelines for Epidemiological Studies, and the applicable regulatory requirements. The study was approved by the <i>Comité consultatif sur le traitement de l’information en matière de recherche dans le domaine de la santé</i> (CCTIRS; approval number 11026) and the <i>Commission Nationale de l’Informatique et des Libertés</i> (CNIL; approval number 911018).
: All patients provided their written informed consent.
: During the last 5 years, Philip Gorwood has received fees for presentations at congresses or participation in scientific boards from Alcediag-Alcen, Angelini, GSK, Janssen, Lundbeck, Otsuka, SAGE and Servier. Over the last 10 years, Jacques Benichou has received fees for participation in scientific boards from Astra Zeneca, Pierre Fabre, IRIS and Research Triangle Institute. Nicolas Moore has received honoraria from the Servier Scientific Committee. Marine Wattez, Marie-Cécile Secouard, Xavier Desobry, Françoise Picarel-Blanchot and Christian de Bodinat are employees of Servier.